comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 20:15:04 - browse：31

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： NYU Langone launches private ChatGPT for its health care data

leisure time

entertainment

WSS

Studies point to risks of excluding people with obesity from drug trials

FDA panel gives mixed vote on blood pressure devices

STAT Readout Newsletter: Today's biggest biotech updates

Medicare reduced heart disease by changing how it pays doctors

Psilocybin's anti

UnitedHealth’s board chair also owns a personal investment firm

focus

comprehensive

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

How one medical school became remarkably diverse

Psilocybin's anti

Cancer drug shortages should be causing more outrage

STAT Readout Newsletter: Today's biggest biotech updates

Dobbs anniversary: the lost opportunity of abortion as health care

HHS leader on health, climate change and biopharma emissions

At least 13 dead in Texas as scorching temps continue

Psilocybin's anti

Malaria cases in Florida and Texas: Here’s what you need to know

FDA struggles to regulate food additives, sometimes for decades

hotspot

Solve the antibiotic resistance crisis with preventive drugs

How a symptom of dementia informs our understanding of creativity

Radiation, mainstay of cancer treatment, begins a fade

Departing Stanford president retracts two papers

Medicare explains how it will choose drugs for negotiation

Solve the antibiotic resistance crisis with preventive drugs

knowledge

entertainment

focus

knowledge